Patents-Review.com
🔗 Permalink
Assignee profile:

CONJUCHEM, INC.

City:

Montreal

Country:

Canada

Published Applications:

15

Last publication date:

2006-12-05

Patent Grants:

14

Last grant date:

2006-12-05

Top Inventors for applications by CONJUCHEM, INC.

These are the the leading inventors for applications assigned to CONJUCHEM, INC.:

Recent patent applications by CONJUCHEM, INC.

CONJUCHEM, INC. based in Montreal, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2006-12-05 ✅ Patent 7,144,854 granted on 2006-12-05
US9657431
-

Long lasting anti-angiogenic peptides

 #2 | 2006-09-26 ✅ Patent 7,112,567 granted on 2006-09-26
US10203808
-

Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders

 #3 | 2006-08-15 ✅ Patent 7,090,851 granted on 2006-08-15
US9657336
-

Long lasting fusion peptide inhibitors of viral infection

 #4 | 2006-06-22 ✅ Patent 8,093,206 granted on 2012-01-10
US20060135426A1
Chemistry; metallurgy

Methods involving long lasting synthetic exendin-4 peptide conjugates

 #5 | 2006-03-16 ✅ Patent 8,084,414 granted on 2011-12-27
US20060058235A1
Chemistry; metallurgy

Methods involving long lasting synthetic exendin-4-peptide conjugates

 #6 | 2006-01-12 ✅ Patent 8,080,516 granted on 2011-12-20
US20060009377A1
Chemistry; metallurgy

Long lasting synthetic exendin-4 peptide conjugates

 #7 | 2005-12-01 ✅ Patent 7,307,148 granted on 2007-12-11
US20050267293A1
Chemistry; metallurgy

Method for purification of albumin conjugates

 #8 | 2005-08-25 ✅ Patent 7,256,253 granted on 2007-08-14
US20050187159A1
Chemistry; metallurgy

Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components

 #9 | 2005-08-11 ✅ Patent 7,601,691 granted on 2009-10-13
US20050176643A1
Chemistry; metallurgy

Anti-obesity agents

 #10 | 2005-08-11
US20050176641A1
Human necessities

Long lasting natriuretic peptide derivatives

 #11 | 2005-05-03 ✅ Patent 6,887,849 granted on 2005-05-03
US10288340
-

Long lasting synthetic glucagon-like peptide {GLP-1}

 #12 | 2005-05-03 ✅ Patent 6,887,470 granted on 2005-05-03
US9657276
-

Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components

 #13 | 2005-03-31 ✅ Patent 7,608,271 granted on 2009-10-27
US20050070475A1
Chemistry; metallurgy

Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group

 #14 | 2005-02-17 ✅ Patent 7,166,695 granted on 2007-01-23
US20050037974A1
Human necessities

Affinity markers for human serum albumin

 #15 | 2005-02-01 ✅ Patent 6,849,714 granted on 2005-02-01
US9623548
-

Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
AssigneeID:

288632 ⎘